Skip to main navigation Skip to search Skip to main content

(Lys9)GLP-1 lacks insulinotropic activity but acts as a potent novel GLP-1 receptor antagonist in vivo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)43-43
JournalDiabetic medicine
Volume21 (S2
Publication statusPublished (in print/issue) - 2004

Cite this